Law360, New York (February 08, 2012, 2:17 PM ET) -- Watson Laboratories on Wednesday announced that it has entered into an agreement with a Johnson & Johnson subsidiary by which the company will issue to Watson a generic version of J&J's Ortho Tri-Cyclen Lo birth control drug, days after the parties settled a related patent infringement suit in New Jersey.
Beginning on December 31, 2015, Watson will be authorized to sell the generic version of J&J's oral contraceptive pill, as per a supply agreement struck between the companies, Watson said in its notice.
The announcement comes...
Watson, J&J Settle Over Birth Control Generic
To view the full article, take a free trial now.
